Meta-Analyses of Methionine Source Concept Validation Trials in Broilers.

Animals (Basel)

Evonik Operations GmbH, 63457 Hanau, Germany.

Published: June 2024

While the supplementation of methionine (Met) sources in broiler feeds has been established for several decades, there is debate on the nutritional value of the methionine hydroxy analogue of methionine (MHA) relative to DL-Met. Based on a recommendation suggesting that MHA is 65% as effective as DL-Met, many feeding trials have been conducted to challenge this recommendation. A literature search found 25 publications contributing 95 data sets suitable to compute Hedges' g effect sizes used in the meta-analysis. The data had very little heterogeneity of almost zero and the small effect sizes of the DL-Met results were not significantly different from MHA. Data were split in various subgroups, finally suggesting that neither broiler strain (Cobb 500, Ross 308), diet type (corn, wheat based), origin of data (peer-reviewed, grey literature), nor MHA product (MHA-free acid, MHA-calcium salt) impacted the outcome of the meta-analysis. Moreover, distinguishing data in groups with dietary Met+Cysteine (Cys) levels below, at, or above requirement demonstrated that there was no interaction with general Met+Cys supply. It is therefore concluded that MHA products can be replaced by DL-Met in a weight-to-weight ratio of 100:65 in any production condition without compromising broiler performance.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11605227PMC
http://dx.doi.org/10.3390/ani14121771DOI Listing

Publication Analysis

Top Keywords

mha
5
data
5
meta-analyses methionine
4
methionine source
4
source concept
4
concept validation
4
validation trials
4
trials broilers
4
broilers supplementation
4
supplementation methionine
4

Similar Publications

The complex (BCC) is a group of Gram-negative bacteria that cause opportunistic infections, most notably in people with cystic fibrosis (CF), and have been associated with outbreaks caused by contaminated medical products. Antimicrobial susceptibility testing (AST) is often used to guide treatment for BCC infections, perhaps most importantly in people with CF who are being considered for lung transplant. However, recent studies have highlighted problems with AST methods.

View Article and Find Full Text PDF

Global urban greening and its implication for urban heat mitigation.

Proc Natl Acad Sci U S A

January 2025

School of Politics and Public Administration, Soochow University, Suzhou 215006, China.

Urban vegetation provides essential ecosystem services and benefits to support biodiversity and human well-being in urban areas. However, the dynamic trends, driving factors, and their implications to urban heat mitigation at the global scale remain largely unclear. Here, we used a high-resolution enhanced vegetation index (EVI) dataset to examine the vegetation dynamics in 11,235 urban areas worldwide, identify the driving factors behind its changes, and estimate the potential urban heat mitigation benefits of these changes.

View Article and Find Full Text PDF

The potential for Safewards to reduce restrictive interventions for people arriving to the emergency Department with police for a mental health assessment.

Int Emerg Nurs

January 2025

Department of Nursing, Faculty of Medicine, Dentistry and Health Sciences, 161 Barry Street, The University of Melbourne, Victoria 3010, Australia. Electronic address:

Unlabelled: Safewards is a complex intervention developed to promote a therapeutic response to minimise conflict and containment in inpatient mental health settings. A pilot study was conducted to adapt Safewards for the emergency department (ED) setting to evaluate its impact on the use of restrictive interventions. This subgroup analysis focusses on patients transported to the ED by police for mental health assessment.

View Article and Find Full Text PDF

Background: The impact of nonneutralizing antibodies (NNAs) in moderate hemophilia is elusive.

Objectives: To explore the presence of NNAs in Nordic persons with moderate hemophilia A (MHA) and B (MHB) in relation to treatment modality, clinical outcome, history of inhibitor, and the corresponding factor VIII (FVIII)/factor IX (FIX) gene mutation.

Methods: A cross-sectional multicenter study covering persons with MHA and MHB in Sweden, Finland, and Norway.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!